Pep AI

A new drug category created a new set of daily questions. He wrote them all down.

Mobile appsGLP-1 trackeriOS appStudent founder
Visit website
Monthly revenue$60K
Time to $10K MRR49 days
Team size1

Pep AI is an iOS app for people on GLP-1 medications such as semaglutide and tirzepatide. It helps track injections and doses, log side effects and meals, and see progress over time. Founder Cedric Roberge launched it in February 2026 and reached $10K in monthly recurring revenue within 49 days, with publicly reported revenue since rising to around $60K a month.

Riding the GLP-1 wave

A new drug category does something useful for product builders: it creates a population of people with a fresh, repetitive, unanswered set of questions. When millions of patients start injecting weekly medication, they immediately want to know when the next dose is due, whether a symptom is normal, whether they ate enough protein, and whether the weight is actually moving. Existing fitness apps were built for a different job.

Pep AI is deliberately narrow — one condition, one routine — and that narrowness is why it can be good. It does not try to be a general health tracker; it tries to answer the questions a GLP-1 patient has this week. The app is explicitly a tracking tool, not medical advice, and treatment decisions stay with clinicians.

49 days from zero to $10K

The growth came from where the patients already gather rather than from a broad campaign. GLP-1 communities are large, vocal, and constantly asking each other which app to use — a natural word-of-mouth channel that costs nothing to enter if the product actually answers the question. App Store search for the drug names does the rest.

The notable thing is the ratio. A one-person app reaching $60K a month in a category this young is unusual, and it is a reminder that a platform shift (new drugs, new devices, new AI capability) is usually worth more to a small builder than a new feature in a crowded category.

Estimates, not audited figures · Last updated: 2026-10-15

Related profiles

Keep exploring

110 profiles and counting — let fate pick the next one.

Frequently asked questions

What is Pep AI?

An iOS tracking app for people using GLP-1 medications — dose and injection logging, side-effect and meal notes, and progress over time. It is a tracking tool, not medical advice.

How fast did Pep AI grow?

The founder has reported reaching $10K in monthly recurring revenue within 49 days of launch and roughly $60K a month afterwards.

Who built Pep AI?

Cedric Roberge, a solo founder based in the United States, who launched it in February 2026.